New therapeutic agents marketed in 1995.
Hussar
D A
DA
Philadelphia College of Pharmacy and Science, USA.
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D020909:Acarbose; D019386:Alendronate; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D002257:Carbonic Anhydrase Inhibitors; D017277:Drug Approval; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D064747:Lansoprazole; D008687:Metformin; D009853:Omeprazole / Q000031:analogs & derivatives; D011245:Pregnadienes; D013449:Sulfonamides; D013876:Thiophenes; D014312:Trisaccharides; D014481:United States; D014486:United States Food and Drug Administration
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D002257:Carbonic Anhydrase Inhibitors; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D011245:Pregnadienes; D013449:Sulfonamides; D013876:Thiophenes; D014312:Trisaccharides; D064747:Lansoprazole; D008687:Metformin; C062765:dorzolamide; D009853:Omeprazole; C013769:rimexolone; D020909:Acarbose; D019386:Alendronate